Delxone TZ 250mg/31.25mg Injection
Marketer
Dr. Edwin Lab
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Delxone TZ 250mg/31.25mg Injection
Combiflox TZ, a 250mg/31.25mg injectable formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, even with symptom improvement, as premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects warrant immediate medical attention. Seek immediate medical assistance for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if experiencing somnolence or vertigo. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your physician may order laboratory and imaging studies to monitor treatment response.
Uses of Delxone TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Delxone TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Delxone TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Delxone TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Delxone TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg (Delxone TZ Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to survive. Tazobactam counters bacterial resistance, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Delxone TZ 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Delxone TZ (250mg/31.25mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies remain scarce.
Breast feedingCAUTION
Administering Delxone TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Delxone TZ 250mg/31.25mg Injection can potentially reduce vigilance, impair visual acuity, and induce drowsiness or dizziness. Operation of a vehicle should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Delxone TZ 250mg/31.25mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Delxone TZ 250mg/31.25mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Delxone TZ 250mg/31.25mg Injection dosage is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Delxone TZ 250mg/31.25mg Injection :
Should you omit a scheduled dose of Delxone TZ 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Delxone TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently